IceCure Medical Ltd. January 2025 Report: Patent Notice for Cryoablation Technology

Here's a summary of the key information extracted from the financial report:

Company Information

• Name: IceCure Medical Ltd.
• Address: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504 Israel
• Reporting Period: Month of January 2025
• Commission File Number: 001-40753

Filing Details

• Type of Filing: Form 6-K (Report of Foreign Private Issuer)
• Filing Date: January 3, 2025

Key Event

• Press Release: The company issued a press release titled “European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology.”
• Exhibit Reference: The press release is attached as Exhibit 99.1 to the Form 6-K.

Registration Statements

• The first and third paragraphs of the press release, along with the section titled "Forward Looking Statements," are incorporated by reference into the Company’s Registration Statements on Form F-3 and Form S-8, indicating the ongoing relevance of this information in regulatory filings.

Signatory Information

• Name: Eyal Shamir
• Title: Chief Executive Officer
• Signature Date: January 3, 2025

Insights

• The issuance of a patent notice is significant as it suggests advancements in IceCure's technology, potentially enhancing its competitive position in the medical technology market.
• The reference to the incorporation of this press release in other registration statements indicates the importance of this announcement for investors and stakeholders, as it might influence the company’s market perception and valuation.

This report demonstrates IceCure Medical Ltd.'s proactive communication regarding its technological developments and regulatory compliance status.